Investigational Asthma Treatment Targets Key Molecules
Two potential asthma treatments that target key molecules to prevent immune cells from triggering asthma attacks, offering the possibility of long-term relief.
Tag: immunology and immunotherapy
All
Latest
Investigational Asthma Treatment Targets Key Molecules
Two potential asthma treatments that target key molecules to prevent immune cells from triggering asthma attacks, offering the possibility of long-term relief.
Read More
New Guidance Seeks to Ease Documentation Hurdles for Allergy Shot Claims
Recommendations from ACAAI, AAAAI, and AAOA aim to simplify documentation requirements for allergen immunotherapy claims to prevent undue burden on healthcare providers and ensure timely patient access.
Read More
FDA Approves Durvalumab-Chemo Combo for Resectable NSCLC
The approval was based on trial results which showed the regimen reduced the risk of recurrence, progression, or death by 32% versus neoadjuvant chemotherapy alone.
Read More
NIH Grant Funds Research into Neutrophils’ Role in Lung Health
The $12 million NIH grant will fund research on how lung neutrophils contribute to injury, inflammation, and repair in severe respiratory conditions.
Read More
AI-Powered Immunotherapy Ends Milk Allergy Restrictions for Kids
The Food Allergy Institute’s study shows that 100% of participants achieved milk allergy remission, with results maintained for at least a year.
Read More
Anti-Inflammatory Approach Succeeds in Lung Cancer Trial
The novel approach has yielded a 67% overall response rate in a small clinical trial for patients with advanced non-small cell lung cancer.
Read More
Peanut Consumption in Infancy Cuts Allergy Risk by 71% in Adolescence
Regular peanut consumption from infancy to age 5 significantly reduces the risk of developing a peanut allergy later in life, even if peanut intake varies in subsequent years, research finds.
Read More
First Guidelines Released for Oral Immunotherapy in Children
Researchers have crafted the first-ever guidelines to standardize the preparation process for families considering oral immunotherapy.
Read More
Macrophages Hidden in Pleural Cavity Attack Lung Viruses
During influenza infection, macrophages in the pleural cavity cross into the lungs where they decrease inflammation and reduce levels of disease.
Read More
New Clinical Practice Guideline for Immunotherapy for Inhalant Allergy
The guideline provides 12 evidence-based key action statements to guide clinicians in treating patients experiencing symptoms from inhalant allergies.
Read More
New Cell Identified as Allergy Memory Keeper
Researchers have discovered a new type of memory B cell that plays a crucial role in remembering and reacting to allergens, a discovery they say could open new avenues for allergy treatment.
Read More
Immune Cells Shape Lung Before Birth
Immune cells play an active and intimate role in directing the growth of human lung tissue during development, researchers find, revolutionizing our understanding of early lung development and the role of immune cells outside of immunity.
Read MoreLiquid Biopsy Predicts Immunotherapy Response in Advanced Lung Cancer
Liquid biopsy to study genetic material from tumors shed into the bloodstream together with immune cells helps predict response to immunotherapy.
Read More
Dupilumab May Help Treat Lung Cancer, Reduce Tumors
Combining immunotherapy with dupilumab boosted lung cancer patients’ immune systems, with one out of the six experiencing significant tumor reduction, according to findings published in Nature.
Read More
How Body Weight Affects Immune Response to COVID-19
Being overweight can impair the body’s antibody response to SARS-CoV-2 infection, but not to the protection offered by vaccination.
Read More
AI Models May Predict Patient Response to Immunotherapies
GE Healthcare’s Artificial Intelligence (AI) models predict patient response to immunotherapies with 70% to 80% accuracy, based on a pan-cancer cohort, according new data to be presented at SITC 38th Annual meeting.
Read More
Immunotherapy Before and After Surgery Boosts Lung Cancer Outcomes
Pre- and post-surgical immunotherapy, combined with chemotherapy, improved survival rates for patients with operable non-small cell lung cancer in a phase 3 trial.
Read More
Immune-Affecting Drugs Amplify COVID-19 Severity
People taking some immune-affecting medications, including prednisone and mycophenolate mofetil, face significantly higher risks of severe COVID-19 outcomes, reveals a new study.
Read More
Triple COVID-19 Vaccine Dose Boosts Antibody Response in Vulnerable
A study reveals promising results for even vulnerable individuals, those at high risk of severe COVID-19, who received three doses of mRNA vaccine.
Read More
Babies’ Weak Spot and Strength in Coping with Respiratory Infections
Two new studies explain why babies get so many common respiratory infections and identify a specialized cluster of immune cells found only in babies that help them better cope with new pathogens.
Read More
Insomnia Spikes Risk of Respiratory Infections
A study involving over 600,000 participants revealed a significantly elevated risk of respiratory infection among individuals diagnosed with insomnia.
Read More
Skin Patch Desensitizes Toddlers with Peanut Allergy
A phase 3 clinical trial found that year-long immunotherapy through a skin patch safely desensitized toddlers with peanut allergy, lowering the risk of a severe allergic reaction from accidental exposure.
Read More
Minority Patients Undertreated with Allergy Shots
Penn State College of Medicine researchers found Black patients were significantly less likely to be prescribed allergy shots than their white counterparts.
Read More
Previous SARS-CoV-2 Infection Weakens Immune-cell Response to Vaccination
The magnitude and quality of a key immune cell’s response to vaccination with two doses of the Pfizer-BioNTech COVID-19 vaccine were considerably lower in people with prior SARS-CoV-2 infection compared to people without prior infection, according to a study published in Immunity.
Read More